Frontiers in Neurology & Neuromuscular Research 2027
Theme : “Integrating Genomics, AI and Neurotechnology in Neurology & Neuromuscular Medicine”
Dubai, UAE | 17 March, 2027
Organized by Pulsecon Global – www.pulseconglobal.com
About the Conference
Frontiers in Neurology & Neuromuscular Research 2027 will convene world-leading neurologists, neuroscientists, geneticists, clinician-scientists, and AI innovators on March 17, 2027, in Dubai, United Arab Emirates (UAE). Guided by the theme “Integrating Genomics, AI and Neurotechnology in Neurology & Neuromuscular Medicine,” this premier international congress marks a decisive transition in neurology—from descriptive and symptomatic care toward molecular intervention, intelligent diagnostics, and restorative neurotechnology.
​
At a pivotal moment in biomedical science, NeuroFrontiers 2027 explores the powerful convergence of genomic medicine, artificial intelligence, and neuroengineering. The scientific program will highlight breakthroughs in neurogenomics, multi-omics integration, AI-driven diagnostics, computational neuroscience, neuromuscular therapeutics, brain–machine interfaces, and closed-loop neuromodulation systems. Sessions will examine how generative AI is accelerating drug discovery, how precision gene therapies are reshaping disease trajectories, and how neurotechnologies are enabling recovery and functional restoration previously considered unattainable.
​
With keynote lectures, translational symposia, and interactive workshops, NeuroFrontiers 2027 fosters high-level interdisciplinary collaboration and global knowledge exchange. Hosted in Dubai—one of the world’s leading hubs for neuroscience and biomedical innovation—the conference invites the global community to help define the next frontier of precision and restorative neurology, where genomics, artificial intelligence, and neurotechnology converge to transform patient care and neurological outcomes.
Why Attend?
-
Gain insights from global leaders in neurology and neuromuscular research
-
Access the latest breakthroughs in clinical and translational science
-
Network with peers, industry innovators, and policymakers
-
Participate in interactive workshops, live demos, and case discussions
-
Present your work and receive recognition through awards
-
Explore collaboration opportunities with academic and industry partners
One Days Agenda Program
NeuroFrontiers 2027, Dubai, UAE
March 17, 2027
Frontiers in Neurogenetics, AI & Clinical Innovations
08:30 AM – 09:00 AM
Registration & Welcome Coffee
09:00 AM – 09:20 AM
Opening Ceremony & Welcome Remarks
09:20 AM – 10:00 AM
Keynote 1: “Shaping the Future of Neuromuscular Research: From Genes to Global Health”
10:00 AM – 11:15 AM
Plenary: Neurogenetics and AI in Neurology
-
Track 1: Neurogenetics & Gene Therapies
-
Track 2: AI in Neurodiagnostics & EMG
-
Track 13: Ethical AI & Rare Disease Diagnostics
11:15 AM – 11:30 AM
Coffee Break
11:30 AM – 12:45 PM
Parallel Scientific Sessions
-
Track 3: Spinal Cord Stimulation & Neuromuscular Recovery
-
Track 4: Surgical Frontiers in Peripheral Nerve Injuries
-
Track 7: TMS & Neuromuscular Plasticity
12:45 PM – 13:45 PM
Networking Lunch
13:45 PM – 15:00 PM
​Parallel Scientific Sessions
-
Track 5: Neuroepidemiology & Forecasting Rare Disorders
-
Track 6: Neuro‑Immune Interactions
-
Track 8: AI & Multimodal Imaging for Neuro‑Muscular Diagnosis
15:00 PM – 15:30 PM
Coffee Break
15:30 PM – 16:30 PM
Panel: Equity & Access in Neuromuscular Care
-
Track 9: Global Health & Equity
-
Track 18: Sex, Gender & Hormonal Influences
16:30 PM – 17:00 PM
Poster & Networking Session
17:00 PM – 17:30 PM
​Closing Plenary Day 1: “From Bench to Bedside: Translating Neuro‑Muscular Discoveries”
Note: Exact speakers, rooms and chairpersons will be assigned in the final program.
Who Should Attend?
The conference is open to professionals across the healthcare, academic, and industry spectrum, including:
Neurologists, Neurosurgeons & Neuroscientists
Data Scientists, AI Experts, & Biomedical Engineers​
​Neuromuscular Specialists & Rehabilitation Experts
Policy Makers & Global Health Leaders
Geneticists & Molecular Biologists
Pharma, Biotech, and MedTech Industry Professionals
Pediatric & Geriatric Neurology Professionals​
Students, Residents, and Early-Career Investigators​
Scientific Sessions
Track 1: Neurogenetics and Gene Therapies Across the Motor Axis
This track focuses on genetic therapies such as CRISPR, viral vectors, and ASOs for SMA, ALS, and dystrophies. It covers clinical trials, newborn screening, ethics, and equitable access
Track 2: Artificial Intelligence in Neurodiagnostics and Electromyography
Explores AI-powered EMG and electrophysiology interpretation, predictive modeling, and clinical integration, addressing accuracy, bias, and clinical validation
Track 3: Spinal Cord Stimulation and Neuromuscular Recovery​​
Covers neuromodulation technologies restoring mobility after injury, rehabilitation protocols, clinical outcomes, and device engineering innovations
​
Track 4: Surgical Frontiers in Peripheral Nerve Injuries
Highlights microsurgery, grafting, bioengineered scaffolds, imaging, and intraoperative advances to optimize nerve repair and recovery
Track 5: Neuroepidemiology and Forecasting Rare Disorders
Focuses on big data, global registries, and analytics to predict disease burden, shape policies, and identify underserved populations
Track 6: Neuro-Immune Interactions in Neuromuscular Disease
Explores autoimmune neuropathies, inflammatory myopathies, biomarkers, and therapeutic immunomodulation strategies
​
Track 7: Transcranial Magnetic Stimulation and Neuromuscular Plasticity
Examines non-invasive brain stimulation in recovery, motor reorganization, ALS, and dystonia, with focus on translational protocols
Track 8: AI and Multimodal Imaging for Integrated Neuro-Muscular Diagnosis
Integrates AI with MRI, PET, CT, ultrasound for precision diagnosis, addressing data validation and clinical integration
​
Track 9: Global Health and Equity in Neuromuscular Care​​
Explores disparities in neuromuscular care access, global policy frameworks, and collaborative approaches for equity
​
Track 10: Neurodevelopment and Pediatric Neuromuscular Syndromes
Addresses early-onset syndromes, pediatric gene therapies, supportive care, and long-term management strategies
​
Track 11: Neurovascular Coupling and Muscle Recovery Post-Stroke
Examines brain-muscle vascular dynamics, imaging biomarkers, and integrated rehabilitation strategies
​
Track 12: Neuro-Robotics and Functional Limb Restoration
Highlights prosthetics, robotics, BMIs, and rehabilitation integration, emphasizing usability and adoption
​
Track 13: Ethical AI and Rare Disease Diagnostics
Covers algorithmic fairness, transparency, patient privacy, and responsible AI in rare disease care
​
Track 14: Omics and Systems Biology in Movement Disorders
Explores genomics, proteomics, metabolomics, systems modeling, and translational applications in movement disorders
Track 15: Post-Viral Neuromuscular Syndromes and Long COVID
Covers neuropathies, fatigue, and neuromuscular syndromes linked to infections, with rehabilitation and care models
Track 16: Virtual Reality and Mixed Reality in Neurorehabilitation
Highlights immersive VR/MR tools for rehabilitation, patient engagement, and cost-effective scalability
​
Track 17: Drug Repurposing in Neurology and Neuromuscular Disease
Focuses on adapting existing drugs for new indications, clinical trial case studies, and translational speed
​
Track 18: Sex, Gender, and Hormonal Influences in Neuro-Muscle Disorders
Examines biological and hormonal influences, gender-specific outcomes, and tailored interventions
​
Track 19: Fatigue, Aging, and Brain-Muscle Crosstalk
Covers neural and mitochondrial changes driving fatigue in aging, prevention, and rehabilitation strategies
​
Track 20: Nutrition, Mitochondria, and Neuromuscular Optimization
Explores nutrition, diet, and metabolic interventions to optimize neuromuscular function and resilience
​
Track 21: Computational Neuroscience​
​
Highlights computational models, neural simulations, AI algorithms, and their application in neurology research
​
Track 22: Parkinson's Disease
​​​
Dedicated to Parkinson’s care innovations including biomarkers, DBS, digital monitoring, and patient-centered management
Track 22: Neuro-AI and Large Language Models in Clinical Neurology​
Examines AI and LLMs for clinical decision support, EHR integration, and research acceleration
​
Track 24: Brain–Gut–Muscle Axis in Neurological and Neuromuscular Disorders
Covers microbiome-brain-muscle interactions, diet influences, and translational therapeutic strategies
​
Submit Abstract
Abstracts must be ≤300 words, structured into Background, Methods, Results, and Conclusion. Each submission should include author details and 5–8 keywords. All abstracts are peer-reviewed and notifications of acceptance are issued within 24–48 hours. Accepted abstracts will appear in the official proceedings and be eligible for awards
Key Dates:
Abstract Submission Opens: 15 March 2027​
Early Submission Deadline: 10 January 2027
Final Submission Deadline: 05 January 2027
Notification of Acceptance: After 24hrs Abstract Submission
Presenter Registration Deadline: 10 January 2027
Participation Benefits
All participants of NeuroFrontiers 2027 will gain benefits that go beyond attendance. The congress is designed to ensure knowledge-sharing, professional growth, and recognition. Benefits include
-
Full access to keynotes, sessions, workshops, and the Innovation Forum.
-
Certificate of Participation (with CME/CE credits if applicable)
-
Eligibility for research awards and recognition
-
Opportunities to present work in oral, poster, or e-poster formats
-
High-value networking with peers, industry experts, and global leaders
-
Exclusive exposure to publishing opportunities and professional collaborations
Venue
About Dubai, UAE
Dubai, a leading emirate of the United Arab Emirates (UAE), is one of the world’s most dynamic and internationally connected cities — a global hub for business, healthcare, research, innovation, and culture. Renowned for its remarkable blend of tradition and modern development, Dubai offers an ideal setting for an international conference on neurology and neuromuscular research.
​
With excellent global connectivity through Dubai International Airport (DXB), the city welcomes delegates from around the world. Dubai offers world-class conference venues, a wide range of accommodation options, advanced healthcare facilities, and an efficient transportation network including the Dubai Metro, buses, taxis, and trams.
In late September, Dubai experiences warm weather, while its extensive air-conditioned indoor facilities provide a comfortable environment for international visitors. Delegates can explore iconic attractions such as the Burj Khalifa, Museum of the Future, Dubai Mall, Palm Jumeirah, and Dubai Marina, along with the city's rich cultural and culinary experiences.
Dubai's multicultural environment, international outlook, and excellent infrastructure create an inspiring setting for scientific exchange, networking, collaboration, and knowledge sharing.
​
Hosting NeuroFrontiers 2027 in Dubai offers delegates not only a high-impact academic experience but also the opportunity to experience the vibrant energy, innovation, and hospitality of one of the world's leading international destinations.
Market Analysis
The neurology and neuromuscular space is undergoing rapid transformation, fueled by breakthroughs in genetics, AI, and rehabilitative technology. Here are updated insights into market size and trends:
-
The neuromuscular disease therapeutics market will expand from USD 11.89 billion in 2023 to ~USD 45.62 billion by 2033.
-
The neurology devices market will reach ~USD 21.28 billion by 2030, growing at ~8.90% CAGR.
-
Digital health in neurology is expected to hit USD 130.8 billion by 2030, at ~22.2% CAGR.
-
Gene & nucleic acid therapies for neuromuscular diseases will rise from USD 9.4 billion (2025) to ~USD 23.4 billion by 2035.​
Key drivers include aging populations, growing prevalence of neurodegenerative diseases, precision medicine, AI diagnostics, wearables, and investment flows. Challenges remain in global access, regulatory hurdles, data privacy, and equitable distribution.
NeuroFrontiers 2027 positions itself as a strategic platform to align academia, industry, and global health leaders in shaping the future of neurology
​Contact Us
Quick Links
Follow Us
Copyright © 2025 - 2026 PulseconGlobal all rights reserved.
Privacy Policy
Cookies Policy